Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have cloned the translocation-associated and homologous normal
MYC
alleles from SKW-3, a leukemia T-cell line with the t(8;14)(q24;q11) translocation, and determined the sequence of the
MYC
oncogene first exon and flanking 5' putative regulatory regions.
S1 nuclease
protection experiments utilizing a
MYC
first exon probe demonstrated transcriptional deregulation of the
MYC
gene associated with the T-cell receptor alpha locus on the 8q+ chromosome of SKW-3 cells. Nucleotide sequence analysis of the translocation-associated (8q+)
MYC
allele identified a single base substitution within the upstream flanking region; the homologous nontranslocated allele contained an additional substitution and a two-base deletion. None of the deletions or substitutions localized to putative 5' regulatory regions. The
MYC
first exon sequence was germ line in both alleles. These results demonstrate that alterations within the putative 5'
MYC
regulatory regions are not necessarily involved in
MYC
deregulation in T-cell leukemias, and they show that juxtaposition of the T-cell receptor alpha locus to a germ-line
MYC
oncogene results in
MYC
deregulation.
...
PMID:Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered. 283 31